Tumor hypoxia in cancer therapy

Area of Science:

• Oncology
• Radiation Oncology
• Cancer Biology

Background:

• Solid tumors exhibit significantly lower oxygen levels than normal tissues, a condition known as tumor hypoxia.
• Tumor hypoxia is a critical factor contributing to resistance to radiotherapy and chemotherapy, and it promotes tumor metastasis.
• Hypoxia and necrosis are distinct characteristics of solid tumors compared to normal tissues, presenting potential therapeutic targets.

Purpose of the Study:

• To investigate the role of tumor hypoxia in radioresistance.
• To explore strategies for exploiting tumor hypoxia and necrosis for cancer treatment.
• To evaluate the physicochemical free radical mechanism underlying oxygen's effect on radiation-induced cell killing.

Main Methods:

• Examination of the physicochemical free radical mechanism of the oxygen effect in sensitizing cells to ionizing radiation.
• Analysis of modeling studies for fractionated irradiation, considering varying oxygen concentrations within tumors.
• Discussion of therapeutic strategies including hypoxia-activated drugs, hypoxia-inducible factor (HIF)-1 gene therapy, and engineered anaerobes for prodrug activation.

Main Results:

• A significant portion of tumor radioresistance is attributed to the physicochemical free radical mechanism of the oxygen effect.
• Tumor cell oxygen concentrations vary widely, necessitating consideration of this spectrum in treatment modeling.
• Prolonged hypoxia leads to tumor necrosis, a characteristic exploitable for therapeutic interventions.

Conclusions:

• Tumor hypoxia plays a major role in radioresistance via the free radical mechanism.
• Therapeutic strategies targeting tumor hypoxia and necrosis, such as hypoxia-activated drugs and gene therapy, hold promise.
• Engineered anaerobic bacteria offer a novel approach to selectively deliver chemotherapy in hypoxic tumor environments.